KEYNOTE-365

12 Mar, 2021

Dr. Rajesh Bollam

Image
🔶KEYNOTE-365 @ASCO #GU21 by Dr. Leonard Joseph Appleman @UPMCHillmanCC
🔶Pembrolizumab+docetaxel in #mCRPC s/p abi/enza, n=104
PSA response (≥50%⬇️): 34%
ORR: 23.1%
rPFS: 8.5 mos
OS: 20.2 mos
👉KN-921, doce vs doce/pembro underway!

Add a comment